Non-fermenting Gram-negative bacilli (NFGNB) including Pseudomonas aeruginosa and Acinetobacter baumannii have been implicated in a variety of infections, particularly in the Intensive Care Units (ICUs). This study was aimed to overview the burden of multidrug-resistant NFGNB causing infections in ICU and also to assess the occurrence of extended-spectrum beta-lactamases (ESBLs), AmpC and metallo-beta-lactamases (MBLs) among these isolates.
may be intrinsically resistant or may have acquired resistance to antibiotics due to impermeability of the cell surface, multidrug efflux pumps and production of β-lactamases [AmpC β-lactamase, extendedspectrum β-lactamases (ESBLs) and metallo-betalactamases (MBLs)] 3 . Multiple beta-lactamaseproducing P. aeruginosa can cause major therapeutic failure and poses a significant clinical challenge. Reports on carbapenemase-producing NFGNB are on the rise globally due to the increased carbapenem usage and selection of resistant bacteria under antibiotic pressure 4 . Therefore, early identification and detection of isolates that produce these enzymes are essential to avoid therapeutic failures and nosocomial outbreaks.
This study was designed to assess the burden of multidrug-resistant P. aeruginosa and A. baumannii in ICU patients. The occurrence of ESBL, AmpC and MBL among these isolates was also assessed.
Material & Methods
The present study was carried out in the department of Microbiology on patients admitted to the ICU of J. N. Medical College, Aligarh Muslim University, Aligarh, India from February 2012 to October 2013. Totally, 125 patients admitted to the ICU were included in the study. A complete history was taken from each patient. Informed written consent was obtained before the study from all the patients, and the study was performed after getting approval from the Institutional Ethics Committee.
The patients were chosen consecutively, and clinical samples were obtained from each patient (endotracheal aspirate, blood, pus, urine). All specimens were collected aseptically and were promptly sent to the microbiology laboratory. All samples were collected within 48 h of the patient admission in the ICU and those collected after 48 h of admission were not included in the study. Wounds (surgical site infections) have been classified according to the Southampton grading 5 . The majority of the cases belonged to Grade IV (purulent discharge along the wound) and Grade V (wound dehiscence). Standard methods for isolation and identification of NFGNB 6 were used.
Susceptibility testing of bacterial isolates was performed using the disc diffusion method as described by the Clinical and Laboratory Standards Institute 7 . Antimicrobial discs used were imipenem (10 µg), cefpodoxime (10 µg), cefotaxime (30 µg), cefepime Phenotypic methods for ESBL detection: NFGNB isolates were first screened for the production of ESBL by the disc diffusion method (screening test) using cefotaxime, ceftriaxone, cefepime and ceftazidime 7 and later on confirmed by the cephalosporin/clavulanate combination disc (disc potentiation test) 8 and doubledisc synergy test 8, 9 . Escherichia coli ATCC 25922 (non-ESBL producer) was used as a control strain.
Phenotypic methods for AmpC detection:
Cefoxitin discs were used to screen AmpC producers, by disc diffusion method 10 . Isolates resistant to cefoxitin were considered as potential AmpC producers.
Phenotypic methods for MBL detection:
The isolates were tested for sensitivity to imipenem (10 μg) using Kirby-Bauer method as recommended by the CLSI 7 . All the isolates with a zone of inhibition ≤16 mm or which demonstrated heaping, or if the zone was >16 but ≤20 mm, were tested for MBL production; however, there is no CLSI guideline for MBL detection available for P. aeruginosa. These isolates were confirmed by modified Hodge test and imipenemethylenediaminetetraacetic acid (EDTA) double-disc synergy test 11, 12 .
Genotypic methods for the detection of ESBL and
AmpC production: Template DNA was prepared from freshly cultured bacterial isolates by suspending bacterial colonies in 50 µl of molecular grade water and then heating at 95°C for five minutes and immediately chilling at 4°C. Molecular detection of bla CTX-M , bla TEM , bla SHV and bla AmpC was performed using polymerase chain reaction (PCR) according to methods described previously with minor modifications (thermal profile of bla CTX-M
12
, primer profiles of bla CTX-M , bla TEM , bla SHV , bla AmpC 13 ). The primers and cycling conditions for detection of bla AmpC genes were the same as those described by Shahid et al 12 and Féria et al 13 . The quality-control strain, Klebsiella pneumoniae ATCC 700603 (ESBL producer) was used.
Results & Discussion
Among the 125 patients admitted to the ICU, 160 isolates were identified. Of these, Gram-negative bacilli, 121 (75.6%) predominated, followed by 22 (13.8%) Gram-positive cocci and 10.6 per cent (n=17) fungal isolates. NFGNB represented 45 (37%) of the Gram-negative isolates (n=121) of which P. aeruginosa (n=35, 29%) was the incriminatory pathogen in majority, followed by A. baumannii (n=10, 8%).
Antimicrobial resistance was observed to be higher in A. baumannii than in P. aeruginosa. Antibiotic resistance pattern of P. aeruginosa and A. baumannii is shown in Table I . Table II 14 .
In other studies, P. aeruginosa represented 15.6 per cent of the total isolates 15, 16 . A. baumannii represented eight per cent of Gram-negative ICU infections in this study. However, other investigators found a higher incidence of A. baumannii (20.5 and 24.1%, respectively) 14, 15 .
In this study, lower respiratory tract infections (LRTIs) were the most common infection in ICU patients (34.3%). Al-Ghamdi et al 17 reported 8.9 per cent LRTIs among ICU cases. In our study, P. aeruginosa and A. baumannii were frequently isolated from LRTIs (40 and 7.3%, respectively), as also shown by Abd El-Fattah 18 . Acinetobacter spp.
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In our study 76.1 and 70.2 per cent of NFGNB were resistant to fluoroquinolones and aminoglycosides, respectively. Antibiotic resistance is a serious problem in developing countries, especially due to the easy availability of antibiotics over the counter 19, 20 . The resistance of P. aeruginosa and A. baumannii to ceftazidime (68.5%, 70%), cefotaxime (57.1%, 70%) and cefpodoxime (65.7%, 70%) was comparable to results reported by others 14, 21 .
Screening by disc diffusion method in this study revealed that 24.3 per cent of NFGNB were ESBL producers. These results were comparable to that of Aggarwal et al 22 , however, lower than results reported by Jiang et al 23 . Confirmation with double-disc synergy test (DDST) and disc combination tests revealed that 18.5 per cent of NF Gram-negative isolates were ESBL producers as also reported by Jiang et al 23 . For AmpC production, both disc diffusion test and screening by cefoxitin disc revealed same results that 51.4 per cent of P. aeruginosa and 50 per cent of A. baumannii isolates were AmpC producers. Similar results were reported by Bhattacharjee et al 24 . The most prevalent gene for ESBL production was bla CTX-M which was detected in 11.4 per cent of Pseudomonas isolates, while bla TEM and bla SHV genes were not detected in any of the isolates. These results were in agreement with Picão and Gales 25 . PCR detected bla AmpC gene in 42.8 per cent of P. aeruginosa and 40 per cent of A. baumannii isolates. These results were comparable to that of Khanal et al 26 .
Comparison between modified Hodge test and DDST in our study revealed that DDST was more sensitive for detecting MBL. The same observation was reported by Jesudason et al 27 . In this study, amikacin, tobramycin, imipenem, polymyxin B and colistin demonstrated maximum sensitivity against NFGNB. Therefore, use of these antibiotics should be restricted to severe infections, especially in critically ill ICU patients, to avoid rapid emergence of resistant strains.
In conclusion, our results showed isolation of a high percentage of NFGNB in ICU patients' samples, which were multidrug resistant and producers of ESBL, AmpC and MBL. A regular surveillance of antimicrobial susceptibility status of such isolates is necessary to curb the infection.
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